N-acetyl-cysteine is a novel adjuvant to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome

Fertility and Sterility

Volumn 83, Issue 2, 2005, Pages 367-370

  Rizk, Ahmed Y ^a,d   Bedaiwy, Mohamed A ^b   Al Inany, Hesham G ^c  

^a BENHA UNIVERSITY   (Egypt)

^b ASSIUT UNIVERSITY   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

^d BENHA UNIVERSITY   (Egypt)

Author keywords

Clomiphene citrate resistance; N acetyl cysteine; Polycystic ovary syndrome; Pregnancy

Indexed keywords

ACETYLCYSTEINE; CLOMIFENE CITRATE; PLACEBO;

ADJUVANT THERAPY; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MULTIPLE PREGNANCY; OVARY DISEASE; OVARY POLYCYSTIC DISEASE; OVULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; UNIVERSITY HOSPITAL;

EID: 13544250688     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2004.07.960     Document Type: Article

References (24)

1. M. Ciampelli, A. Lanzone Insulin and polycystic ovary syndrome: a new look at an old subject Gynecol Endocrinol 12 1998 277 292
2. S. Franks Polycystic ovary syndrome N Engl J Med 333 1995 853 861
3. S. Franks Polycystic ovary syndrome: a changing perspective Clin Endocrinol (Oxf) 31 1989 87 120
4. J.E. Nestler Obesity, insulin, sex steroids and ovulation Int J Obes Relat Metab Disord 24 Suppl 2 2000 S71 3
5. H.Y. Malkawi, H.S. Qublan, A.H. Hamaideh Medical vs. surgical treatment for clomiphene citrate-resistant women with polycystic ovary syndrome J Obstet Gynaecol 23 2003 289 293
6. P. Wentzel, L. Thunberg, U.J. Eriksson Teratogenic effect of diabetic serum is prevented by supplementation of superoxide dismutase and N-acetylcysteine in rat embryo culture Diabetologia 40 1997 7 14
7. A. Lanzone, A.M. Fulghesu, C.L. Andreani, R. Apa, A. Fortini, A. Caruso Insulin secretion in polycystic ovarian disease: effect of ovarian suppression by GnRH agonist Hum Reprod 5 1990 143 149
8. L. Borgstrom, B. Kagedal, O. Paulsen Pharmacokinetics of N-acetylcysteine in man Eur J Clin Pharmacol 31 1986 217 222
9. De Vries N, De Flora S. N-acetyl-l-cysteine. J Cell Biochem 1993;Suppl 17F:270-7.
10. O. Acbay, S. Gundogdu Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil Steril 65 1996 946 949
11. H.J. Coelingh Bennink, B.C. Fauser, H.J. Out Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial European Puregon Collaborative Anovulation Study Group Fertil Steril 69 1998 19 25
12. J. Holte, T. Bergh, C. Berne, L. Berglund, H. Lithell Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance J Clin Endocrinol Metab 78 1994 1052 1058
13. P. Moghetti, R. Castello, C. Negri, F. Tosi, F. Perrone, M. Caputo Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation J Clin Endocrinol Metab 85 2000 139 146
14. P. Weidmann, M. de Courten, L. Bohlen Insulin resistance, hyperinsulinemia and hypertension J Hypertens Suppl 11 Suppl 5 1993 S27 38
15. A.M. Fulghesu, M. Ciampelli, G. Muzj, C. Belosi, L. Selvaggi, G.F. Ayala N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome Fertil Steril 77 2002 1128 1135
16. H.P. Ammon, P.H. Muller, M. Eggstein, C. Wintermantel, B. Aigner, H. Safayhi Increase in glucose consumption by acetylcysteine during hyperglycemic clamp A study with healthy volunteers Arzneimittelforschung 42 1992 642 645
17. G.M. Pieper, W. Siebeneich Oral administration of the antioxidant, N-acetylcysteine, abrogates diabetes-induced endothelial dysfunction J Cardiovasc Pharmacol 32 1998 101 105
18. P. Odetti, C. Pesce, N. Traverso, S. Menini, E.P. Maineri, L. Cosso Comparative trial of N-acetyl-cysteine, taurine, and oxerutin on skin and kidney damage in long-term experimental diabetes Diabetes 52 2003 499 505
19. G. De Mattia, M.C. Bravi, O. Laurenti, M. Cassone-Faldetta, A. Proietti, O. De Luca Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes Diabetologia 41 1998 1392 1396
20. B. Sekhon, C. Sekhon, M. Khan, S.J. Patel, I. Singh, A.K. Singh N-Acetyl cysteine protects against injury in a rat model of focal cerebral ischemia Brain Res 971 2003 1 8
21. M. Lappas, M. Permezel, G.E. Rice N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro J Clin Endocrinol Metab 88 2003 1723 1729
22. R. Azziz, D. Ehrmann, R.S. Legro, R.W. Whitcomb, R. Hanley, A.G. Fereshetian Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial J Clin Endocrinol Metab 86 2001 1626 1632
23. R. Pasquali, A. Gambineri, D. Biscotti, V. Vicennati, L. Gagliardi, D. Colitta Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome J Clin Endocrinol Metab 85 2000 2767 2774
24. A. Dunaif, D. Scott, D. Finegood, B. Quintana, R. Whitcomb The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome J Clin Endocrinol Metab 81 1996 3299 3306